An Open Label Positron Emission Tomography (PET) Study to Investigate Brain Penetration by [11C]GW842166 in Healthy Subjects.
Latest Information Update: 06 Sep 2023
At a glance
- Drugs GW 842166X (Primary)
- Indications Inflammatory pain
- Focus Pharmacokinetics
- Sponsors GSK
- 29 May 2009 New trial record